Diabetes increases risk of heart attack death by 50%

Diabetes increases risk of heart attack death by 50%

June 29 2016 A new study has shown the importance of managing type 2 diabetes to help reduce the...

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

EMA issues warning that Noxafil tablets and oral suspension not interchangeable

June 27 2016 The tablet and oral suspension preparations of Noxafil (posaconazole) are not...

GPhC to address issues relating to workplace pressures

GPhC to address issues relating to workplace pressures

June 22 2016 The General Pharmaceutical Council is look at how pharmacy professionalism is being...

RPS supports introduction of disclosure of pharma payments register for health professionals

RPS supports introduction of disclosure of pharma payments register for health professionals

June 20 2016 The Royal Pharmaceutical Society has supported steps being taken to introduce a...

CPPE Community Pharmacy Competence Group re-launches DoC

CPPE Community Pharmacy Competence Group re-launches DoC

June 13 2016 The Declaration of Competence (DoC) framework has been revised and re-launched with...

  • Diabetes increases risk of heart attack death by 50%

    Diabetes increases risk of heart attack death by 50%

    Wednesday, 29 June 2016 11:43
  • EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    EMA issues warning that Noxafil tablets and oral suspension not interchangeable

    Tuesday, 28 June 2016 13:46
  • GPhC to address issues relating to workplace pressures

    GPhC to address issues relating to workplace pressures

    Wednesday, 22 June 2016 14:19
  • RPS supports introduction of disclosure of pharma payments register for health professionals

    RPS supports introduction of disclosure of pharma payments register for health professionals

    Tuesday, 21 June 2016 11:59
  • CPPE Community Pharmacy Competence Group re-launches DoC

    CPPE Community Pharmacy Competence Group re-launches DoC

    Monday, 13 June 2016 11:30

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

MoneysJune 20 2016

The Royal Pharmaceutical Society has supported steps being taken to introduce a register disclosing payments being made by the pharmaceutical industry to health professionals.

Disclosure of payments will be made public on a register set up by the Association of the British Pharmaceutical Industry, to be launched on June 30. As part of a European-wide initiative to increase transparency, the UK database will publish ‘transfers of value’ from its members to healthcare professionals and organisations.

The database will record:

• event registration fees
• event travel and accommodation costs
• fees and expenses for consultancy or services
• payments for research and development activities
• payments for activities such as sponsorship of programmes and initiatives.

Initially, available data will relate to 2015, but the database will be updated on an ongoing basis.

RPS President Ash Soni said: “I strongly support greater transparency around payments made by the pharmaceutical industry to health professionals and healthcare organisations. This new database is a step in the journey towards greater openness and accountability in the relationships between industry and the health professions.

“Collaboration with the pharmaceutical industry is essential to driving innovation in medicines. It is important it’s fully understood that working with industry ultimately helps drive patient care. Lack of transparency and understanding contributes to lack of confidence in the healthcare professions and their interaction with industry.”

Mr Soni has urged pharmacists to participate in this initiative “and allow disclosure to further build the trust between us and our patients.”

Links:

RPS statement

ABPI disclosure of payments

Practice News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...